|
|
Last Modified: 7/11/2007  First Published: 10/1/1998 |
|
Phase
|
|
|
|
Type
|
|
|
|
Status
|
|
|
|
Age
|
|
|
|
Sponsor
|
|
|
|
Protocol IDs
|
|
|
|
Phase IV
|
|
|
|
Treatment
|
|
|
|
Closed
|
|
|
|
50 and under
|
|
|
|
Other
|
|
|
|
MSGCC-9720 NCI-V98-1428
|
|
|
|
|
|
|
|
Last Modified: 6/1/2001  First Published: 9/1/1998 |
|
Phase
|
|
|
|
Type
|
|
|
|
Status
|
|
|
|
Age
|
|
|
|
Sponsor
|
|
|
|
Protocol IDs
|
|
|
|
Phase IV
|
|
|
|
Treatment
|
|
|
|
Closed
|
|
|
|
50 and under
|
|
|
|
Other
|
|
|
|
MSGCC-9739 NCI-V98-1433, NCT00003398
|
|
|
|
|
|
|
|
Last Modified: 7/11/2007  First Published: 9/1/1998 |
|
Phase
|
|
|
|
Type
|
|
|
|
Status
|
|
|
|
Age
|
|
|
|
Sponsor
|
|
|
|
Protocol IDs
|
|
|
|
Phase IV
|
|
|
|
Supportive care, Treatment
|
|
|
|
Closed
|
|
|
|
Any age
|
|
|
|
Other
|
|
|
|
MSGCC-9721 NCI-V98-1438
|
|
|
|
|
|
|
|
Phase
|
|
|
|
Type
|
|
|
|
Status
|
|
|
|
Age
|
|
|
|
Sponsor
|
|
|
|
Protocol IDs
|
|
|
|
Phase IV
|
|
|
|
Treatment
|
|
|
|
Completed
|
|
|
|
15 and over
|
|
|
|
Other
|
|
|
|
LAL-RI/96 NCT00494897
|
|
|
|
|
|
|
|
Phase
|
|
|
|
Type
|
|
|
|
Status
|
|
|
|
Age
|
|
|
|
Sponsor
|
|
|
|
Protocol IDs
|
|
|
|
Phase III, Phase II
|
|
|
|
Treatment
|
|
|
|
Completed
|
|
|
|
under 21 at relapse
|
|
|
|
NCI
|
|
|
|
POG-9410 POG-SIMAL-8, POG-9410
|
|
|
|
|
|
|
|
Phase
|
|
|
|
Type
|
|
|
|
Status
|
|
|
|
Age
|
|
|
|
Sponsor
|
|
|
|
Protocol IDs
|
|
|
|
Phase III, Phase II
|
|
|
|
Treatment
|
|
|
|
Closed
|
|
|
|
under 75
|
|
|
|
|
|
|
|
CNR-9505 EU-95023
|
|
|
|
|
|
|
|
Last Modified: 5/8/2007  First Published: 11/1/2000 |
|
Phase
|
|
|
|
Type
|
|
|
|
Status
|
|
|
|
Age
|
|
|
|
Sponsor
|
|
|
|
Protocol IDs
|
|
|
|
Phase III, Phase II
|
|
|
|
Treatment
|
|
|
|
Closed
|
|
|
|
Under 46
|
|
|
|
Other
|
|
|
|
UMN-MT-1995-06 UMN-9224, UMN-MT-9506, NCI-V00-1605, NCT00006451
|
|
|
|
|
|
|
|
Last Modified: 7/11/2007  First Published: 4/1/1998 |
|
Phase
|
|
|
|
Type
|
|
|
|
Status
|
|
|
|
Age
|
|
|
|
Sponsor
|
|
|
|
Protocol IDs
|
|
|
|
Phase III, Phase II
|
|
|
|
Treatment
|
|
|
|
Closed
|
|
|
|
55 and under
|
|
|
|
NCI
|
|
|
|
MCV-CCHR-9504-2X DUMC-75951, NCI-G98-1388, NCT00003187
|
|
|
|
|
|
|
|
Last Modified: 7/11/2007  First Published: 2/1/2000 |
|
Phase
|
|
|
|
Type
|
|
|
|
Status
|
|
|
|
Age
|
|
|
|
Sponsor
|
|
|
|
Protocol IDs
|
|
|
|
Phase III, Phase II
|
|
|
|
Supportive care, Treatment
|
|
|
|
Completed
|
|
|
|
12 to 50
|
|
|
|
Other
|
|
|
|
CHIMERIC-HM01 WSU-10-02-99-M01-FB, NCT00004255
|
|
|
|
|
|
|
|
Phase
|
|
|
|
Type
|
|
|
|
Status
|
|
|
|
Age
|
|
|
|
Sponsor
|
|
|
|
Protocol IDs
|
|
|
|
Phase III, Phase II
|
|
|
|
Treatment
|
|
|
|
Closed
|
|
|
|
no age specified
|
|
|
|
|
|
|
|
DFCI-75118
|
|
|
|